Hypoxia-conditioned media allows species-specific attraction of bone marrow stromal cells without need for recombinant proteins.
Abstract: In vivo tissue regeneration depends on migration of stem cells into injured areas, their differentiation into specific cell types, and their interaction with other cells that are necessary to generate new tissue. Human mesenchymal stem cells, a subset of bone marrow stromal cells (BMSCs), can migrate and differentiate into osteoblasts in bone tissue. This can be facilitated by recombinant growth factors and cytokines. In many animal species, the availability of genomic sequences, recombinant proteins, and/or antibodies is limited so that new approaches are needed to generate resources that facilitate migration of stem cells into tissue defect areas. Here we used bone marrow stromal cells of human, ovine, equine, and canine origin to generate hypoxia-conditioned media (HCM) in order to attract BMSCs of the respective species in migration assays. Results: We show that HCM contain attractors even more potent than vascular endothelial growth factor and can therefore be used in many animal species without the need for purified proteins. Conclusions: Generation of HCM is easy and cheap compared to preparation and purification of protein fractions and/or recombinant proteins. Hence, HCM could be applied in large animals (e.g. sheep, horse, dogs) for attraction of BMSCs into tissue defects caused by tumor resection or trauma.
Publication Date: 2014-03-04 PubMed ID: 24593914PubMed Central: PMC3974005DOI: 10.1186/1746-6148-10-56Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research focused on the use of hypoxia-conditioned media to attract bone marrow stromal cells from various species, eliminating the need for expensive recombinant proteins typically used to stimulate the migration of these cells. By using this method, the researchers suggest a cost-effective alternative for tissue regeneration, particularly in larger animals.
Objective of the Research
- The research aimed to develop a new method for stimulating the migration of bone marrow stromal cells (a subset of mesenchymal stem cells) into damaged tissue areas for regeneration.
- The study sought to identify an alternative to the use of recombinant growth factors or cytokines, which are often expensive and limited in availability for many animal species.
Hypoxia-Conditioned Media (HCM)
- The researchers generated Hypoxia-Conditioned Media (HCM) using bone marrow stromal cells from humans, sheep, horses, and dogs.
- HCM was found to contain attractors more potent than the vascular endothelial growth factor, a common recombinant protein used to stimulate cell migration.
- This suggests that HCM can be applied across many animal species to attract bone marrow stromal cells to tissue defects without the need for expensive recombinant proteins.
Implications of the Research
- The development of HCM provides a more cost-effective and universally applicable alternative to the use of recombinant proteins for stem cell migration.
- This new method could be particularly useful for tissue regeneration in large animals, as it circumvents limitations related to the purification and preparation of protein fractions or recombinant proteins.
- As such, HCM has potential applications in the healing of tissue defects caused by trauma or tumor resection.
Conclusions
- The study demonstrated that Hypoxia-Conditioned Media is an efficient and cost-effective alternative to recombinant proteins for stimulating the migration of bone marrow stromal cells into damaged tissues for regeneration.
- This method holds promise for expanding treatment options for large animals and could lead to advancements in veterinary medicine, especially in the field of tissue regeneration.
Cite This Article
APA
Gabrielyan A, Knaak S, Gelinsky M, Arnhold S, Rösen-Wolff A.
(2014).
Hypoxia-conditioned media allows species-specific attraction of bone marrow stromal cells without need for recombinant proteins.
BMC Vet Res, 10, 56.
https://doi.org/10.1186/1746-6148-10-56 Publication
Researcher Affiliations
- Department of Paediatrics, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany. Angela.Roesen-Wolff@uniklinikum-dresden.de.
MeSH Terms
- Amino Acid Sequence
- Animals
- Cell Movement
- Culture Media, Conditioned
- Dogs
- HMGB1 Protein / genetics
- HMGB1 Protein / metabolism
- Horses
- Humans
- Mesenchymal Stem Cells / cytology
- Mesenchymal Stem Cells / physiology
- Oxygen
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic / genetics
- Receptors, Immunologic / metabolism
- Sheep
- Species Specificity
- Vascular Endothelial Growth Factor A / genetics
- Vascular Endothelial Growth Factor A / metabolism
References
This article includes 11 references
- Mishima Y, Lotz M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells.. J Orthop Res 2008 Oct;26(10):1407-12.
- Heino TJ, Hentunen TA. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells.. Curr Stem Cell Res Ther 2008 May;3(2):131-45.
- Thieme S, Ryser M, Gentsch M, Navratiel K, Brenner S, Stiehler M, Rölfing J, Gelinsky M, Rösen-Wolff A. Stromal cell-derived factor-1alpha-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds.. Tissue Eng Part C Methods 2009 Dec;15(4):687-96.
- Boomsma RA, Geenen DL. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis.. PLoS One 2012;7(4):e35685.
- Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, Semenza GL. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1.. J Biol Chem 2006 Jun 2;281(22):15554-63.
- Nehil M, Paquette J, Tokuyasu T, McCormick F. High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A.. Oncogene 2014 Oct 30;33(44):5151-62.
- Meng E, Guo Z, Wang H, Jin J, Wang J, Wang H, Wu C, Wang L. High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway.. Stem Cells Dev 2008 Aug;17(4):805-13.
- Kraus KH, Kirker-Head C. Mesenchymal stem cells and bone regeneration.. Vet Surg 2006 Apr;35(3):232-42.
- Kim JW, Lee JH, Lyoo YS, Jung DI, Park HM. The effects of topical mesenchymal stem cell transplantation in canine experimental cutaneous wounds.. Vet Dermatol 2013 Apr;24(2):242-e53.
- Renzi S, Riccò S, Dotti S, Sesso L, Grolli S, Cornali M, Carlin S, Patruno M, Cinotti S, Ferrari M. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.. Res Vet Sci 2013 Aug;95(1):272-7.
- Kol A, Walker NJ, Galuppo LD, Clark KC, Buerchler S, Bernanke A, Borjesson DL. Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression.. Equine Vet J 2013 Mar;45(2):193-8.
Citations
This article has been cited 8 times.- Richter RF, Vater C, Korn M, Ahlfeld T, Rauner M, Pradel W, Stadlinger B, Gelinsky M, Lode A, Korn P. Treatment of critical bone defects using calcium phosphate cement and mesoporous bioactive glass providing spatiotemporal drug delivery. Bioact Mater 2023 Oct;28:402-419.
- Bretschneider H, Quade M, Lode A, Gelinsky M, Rammelt S, Vater C. Chemotactic and Angiogenic Potential of Mineralized Collagen Scaffolds Functionalized with Naturally Occurring Bioactive Factor Mixtures to Stimulate Bone Regeneration. Int J Mol Sci 2021 May 29;22(11).
- Bretschneider H, Quade M, Lode A, Gelinsky M, Rammelt S, Zwingenberger S, Schaser KD, Vater C. Characterization of Naturally Occurring Bioactive Factor Mixtures for Bone Regeneration. Int J Mol Sci 2020 Feb 19;21(4).
- Stevens NE, Nash CH, Fraser CK, Kuchel TR, Maiden MJ, Chapman MJ, Diener KR, Hayball JD. High mobility group box protein 1 neutralization therapy in ovine bacteremia: Lessons learned from an ovine septic shock model incorporating intensive care support. Exp Ther Med 2019 Nov;18(5):3271-3280.
- Zhang X, Hu F, Li G, Li G, Yang X, Liu L, Zhang R, Zhang B, Feng Y. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling. Cell Death Dis 2018 Jan 18;9(2):25.
- Gabrielyan A, Neumann E, Gelinsky M, Rösen-Wolff A. Metabolically conditioned media derived from bone marrow stromal cells or human skin fibroblasts act as effective chemoattractants for mesenchymal stem cells. Stem Cell Res Ther 2017 Sep 29;8(1):212.
- Pan Z, Tian Y, Zhang B, Zhang X, Shi H, Liang Z, Wu P, Li R, You B, Yang L, Mao F, Qian H, Xu W. YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression. Int J Oncol 2017 Oct;51(4):1055-1066.
- Li W, Zhou Y, Yang J, Zhang X, Zhang H, Zhang T, Zhao S, Zheng P, Huo J, Wu H. Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8. J Exp Clin Cancer Res 2015 May 20;34(1):52.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
